Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 59045L205 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
683 Capital Management, LLC
13G/A
Amendment 2
|
0% |
5/15/2026
Event 3/31/2026
|
|
| 683 Capital Management, LLC | 0% | ||
| 683 Capital Partners, LP | 0% | ||
| Ari Zweiman | 0% | ||
|
683 Capital Management, LLC
13G/A
Amendment 1
|
7.0% |
2/17/2026
Event 12/31/2025
|
|
| 683 Capital Management, LLC | 7.0% | ||
| 683 Capital Partners, LP | 7.0% | ||
| Ari Zweiman | 7.0% | ||
| Vanguard Group Inc 13G/A Amendment 2 | 4.2% |
1/30/2026
Event 12/31/2025
|
|
|
Nextech Crossover I GP S.a r.l.
13G/A
Amendment 3
|
0% |
1/9/2026
Event 1/6/2026
|
|
| Nextech Crossover I GP S.a. r.l. | 0% | ||
| Nextech Crossover I SCSp | 0% | ||
| Ian Charoub | 0% | ||
| Costas Constantinides | 0% | ||
| Rocco Sgobbo | 0% | ||
|
Bain Capital Life Sciences Fund II, L.P.
13D/A
Amendment 8
|
0% |
1/8/2026
Event 1/6/2026
|
|
| Bain Capital Life Sciences Fund II, L.P. | 0% | ||
| BCIP Life Sciences Associates, LP | 0% | ||
| BCLS II Investco, LP | 0% | ||
|
683 Capital Management, LLC
13G
|
5.5% |
11/24/2025
Event 11/17/2025
|
|
| 683 Capital Management, LLC | 5.5% | ||
| 683 Capital Partners, LP | 5.5% | ||
| Ari Zweiman | 5.5% | ||
|
Bain Capital Life Sciences Fund II, L.P.
13D/A
Amendment 7
|
4.0% |
11/13/2025
Event 11/12/2025
|
|
| Bain Capital Life Sciences Fund II, L.P. | 2.6% | ||
| BCIP Life Sciences Associates, LP | 0.3% | ||
| BCLS II Investco, LP | 4.0% |